ELISA Kit for Complement Component 4a (C4a)

C4a anaphylatoxin

Specificity

This assay has high sensitivity and excellent specificity for detection of Complement Component 4a (C4a).
No significant cross-reactivity or interference between Complement Component 4a (C4a) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Complement Component 4a (C4a) and the recovery rates were calculated by comparing the measured value to the expected amount of Complement Component 4a (C4a) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-96 89
EDTA plasma(n=5) 82-101 95
heparin plasma(n=5) 84-94 88

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Complement Component 4a (C4a) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Complement Component 4a (C4a) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Complement Component 4a (C4a) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 83-102% 98-105% 93-101% 99-105%
EDTA plasma(n=5) 78-103% 96-105% 87-95% 79-96%
heparin plasma(n=5) 99-105% 94-101% 88-97% 95-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Vascular Surgery Circulation levels of acute phase proteins in patients with Takayasu arteritis PubMed: 20100644
PLoS ONE Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance PubMed: PMC3754973
PLoS One Higher Serum Angiotensinogen Is an Indicator of IgA Vasculitis with Nephritis Revealed by Comparative Proteomes Analysis PubMed: 26098644
PLoS One Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis PubMed: 25789864
Experimental Eye Research Quantitative analysis of hydroxyapatite-binding plasma proteins in genotyped individuals with late-stage age-related macular degeneration Pubmed:29580721
Diagnostics Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J Pubmed: 32585848
Scientific Reports Maternal Serum Proteomic Profiles of Pregnant Women With Type 1 Diabetes 34940989
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
APA389Mu02 Active Complement Component 4a (C4a) Cell culture; Activity Assays.
RPA389Mu01 Recombinant Complement Component 4a (C4a) Positive Control; Immunogen; SDS-PAGE; WB.
RPA389Mu02 Recombinant Complement Component 4a (C4a) Positive Control; Immunogen; SDS-PAGE; WB.
PAA389Mu02 Polyclonal Antibody to Complement Component 4a (C4a) WB; IHC; ICC; IP.
PAA389Mu01 Polyclonal Antibody to Complement Component 4a (C4a) WB; IHC
SEA389Mu ELISA Kit for Complement Component 4a (C4a) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA389Mu Multiplex Assay Kit for Complement Component 4a (C4a) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.